ѻý

<ѻý class="page-title">Meeting Coverage

CTAD

<ѻý class="page-description">Clinical Trials on Alzheimer's Disease Conference
Alzheimer's Progression May Be Slowed by Targeted Magnetic Pulses, Study Suggests

In phase II trial, transcranial stimulation led to significant differences versus placebo

CTAD
<ѻý class="section_title">Latest CTAD Meeting Coverage
Omega-3 Supplements Show Benefit in APOE4 Carriers

Trial finds DHA can penetrate the brain before dementia onset

November 1, 2024
Leukemia Drug Shows Promise in Dementia With Lewy Bodies

Cognitive outcomes, biomarkers improved with nilotinib in phase II trial

October 30, 2024
Brain Edema Risk May Be Lower With Modified Donanemab Dosing

Different regimen showed comparable pharmacokinetic and pharmacodynamic results

October 29, 2024